Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
- Eli Lilly 近 90 天出现 14 次
- 上一次：同一天稍早 · Eli Lilly's experimental weight loss drug shed 21% of body weight in diabetes trial
发生了什么
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
摘要按规则整理自下方来源原文